{"id":"W3182533416","doi":"10.1080/10428194.2021.1938027","title":"A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignancies","year":2021,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Ibrutinib; Bruton's tyrosine kinase; Diffuse large B-cell lymphoma; Refractory (planetary science); Medicine; Cancer research; Pharmacodynamics; Pharmacology; Internal medicine; Oncology; Lymphoma; Pharmacokinetics; Tyrosine kinase; Chronic lymphocytic leukemia; Biology; Leukemia; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001328802,0.001339286,0.001566973,0.000526388,0.000383862,0.0009958887,0.0006744877,0.001184196,0.003686082],"category_scores_gemma":[0.0006514902,0.0005908914,0.001110662,0.0003992997,0.0006454521,0.0006195327,0.0002739271,0.002355519,0.001040766],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008727388,"about_ca_system_score_gemma":0.001381822,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001144937,"about_ca_topic_score_gemma":0.003203698,"domain_scores_codex":[0.9995376,0.0002293694,0.00001922158,0.00008121641,0.00004477593,0.00008791341],"domain_scores_gemma":[0.9996624,0.00004144162,0.00004679169,0.00002637468,0.00003018049,0.0001927978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5266446,0.1567479,0.007016508,0.001059429,0.001652252,0.0006361412,0.0004637454,0.003572718,0.1010821,0.000713282,0.007455681,0.1929554],"study_design_scores_gemma":[0.5039632,0.4751149,0.008919765,0.00003732157,0.0004268354,0.0003443454,0.00005919839,0.001633073,0.003930032,0.0002436899,0.005295436,0.00003221663],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9836611,0.003150954,0.001010856,0.0006657608,0.0001695979,0.005462454,0.001566602,0.0001396092,0.00417305],"genre_scores_gemma":[0.9788012,0.002706864,0.003582271,0.001277343,0.0002049288,0.005346394,0.002862158,0.00005385036,0.005165071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003686082,"threshold_uncertainty_score":0.01233113,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00943998338930477,"score_gpt":0.2521259848472878,"score_spread":0.2426860014579831,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}